Hepatic arterial infusion chemotherapy with oxaliplatin plus raltitrexed versus oxaliplatin plus fluorouracil in intermediate and advanced hepatocellular carcinoma: A retrospective study.

被引：0
|
作者：
Zang, Mengya
Li, Qi
Hu, Xiaoyun
Yuan, Guosheng
Li, Rong
Guo, Yabing
Chen, Jinzhang
机构：
[1] Southern Med Univ, Hepatol Unit, Nanfang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Dept Infect Dis, Nanfang Hosp, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16166
引用
收藏
页码：E16166 / E16166
页数：1
相关论文
共 50 条
  • [1] Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
    Yang Zhao
    Jia Ying Lai
    Run Bin Liang
    Min Ke He
    Ming Shi
    Journal of Interventional Medicine, 2019, 2 (02) : 78 - 83
  • [2] Lenvatinib plus hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin versus lenvatinib alone for advanced hepatocellular carcinoma.
    Shi, Feng
    Peng, Zhenwei
    Xia, Dongdong
    Mai, Qicong
    Wang, Meng
    Mei, Jie
    Kuang, Ming
    Chen, Xiaoming
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 580 - 580
  • [3] Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study
    Zang, Mengya
    Hu, Xiaoyun
    Yuan, Guosheng
    Li, Rong
    Li, Wenli
    Pang, Huajin
    Li, Qi
    Chen, Jinzhang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [4] Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
    Lyu, Ning
    Kong, Yanan
    Mu, Luwen
    Lin, Youen
    Li, Jibin
    Liu, Yaru
    Zhang, Zhenfeng
    Zheng, Lie
    Deng, Haijing
    Li, Shaolong
    Xie, Qiankun
    Guo, Rongping
    Shi, Ming
    Xu, Li
    Cai, Xiuyu
    Wu, Peihong
    Zhao, Ming
    JOURNAL OF HEPATOLOGY, 2018, 69 (01) : 60 - 69
  • [5] Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization
    Wu, Yanfang
    Zheng, Susu
    Zhang, Zhenzhen
    Chen, Guobin
    Chen, Xiaochun
    Zheng, Tanghui
    Guo, Xinkun
    Chen, Hong
    Wang, Meixia
    Xie, Xiaoying
    Zhang, Boheng
    MEDICINA-LITHUANIA, 2022, 58 (10):
  • [6] Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study
    Chen, Shiguang
    Zhang, Kongzhi
    Liu, Weifu
    Yu, Wenchang
    EUROPEAN JOURNAL OF CANCER, 2020, 134 : 90 - 98
  • [7] Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study
    Khouri, Cedric
    Guiu, Boris
    Cercueil, Jean Pierre
    Chauffert, Bruno
    Ladoire, Sylvain
    Ghiringhelli, Francois
    ANTI-CANCER DRUGS, 2010, 21 (06) : 656 - 661
  • [8] Hepatic arterial infusion of oxaliplatin plus raltitrexed in unresectable hepatocellular carcinoma with or without portal vein tumour thrombosis
    Chen, Shiguang
    Yu, Wenchang
    Zhang, Kongzhi
    Liu, Weifu
    Wang, Xiaolong
    Chen, Chuanben
    GASTROENTEROLOGY REPORT, 2022, 10
  • [9] A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases
    Feng, Ai-Wei
    Guo, Jian-Hai
    Gao, Song
    Kou, Fu-Xin
    Liu, Shao-Xing
    Liu, Peng
    Chen, Hui
    Wang, Xiao-Dong
    Xu, Hai-Feng
    Cao, Guang
    Zhu, Xu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Apatinib plus hepatic arterial infusion of oxaliplatin and raltitrexed for hepatocellular carcinoma with extrahepatic metastasis: phase II trial
    Chen, Shiguang
    Wang, Xiangdong
    Yuan, Bo
    Peng, Jianyang
    Zhang, Qingxian
    Yu, Wenchang
    Ge, Naijian
    Weng, Zhicheng
    Huang, Jinqi
    Liu, Weifu
    Wang, Xiaolong
    Chen, Chuanben
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345